Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Xingtu Helium Energy's First Satellite "Xingtu-1" Passes Feasibility Review
On August 23, 2026, Beijing Xingtu Helium Energy Space Technology Co., Ltd. organized a feasibility review meeting for the Xingtu-1 lunar probe. Experts from aerospace research institutes, renowned universities, and leading commercial space companies formed a review expert panel to evaluate the project plan. At the meeting, the Xingtu Helium Energy model development team presented the "Xingtu-1 Lunar Probe Feasibility Plan Report," covering the probe's technical scheme, project progress, and subsequent implementation arrangements. The review expert panel affirmed the technical scheme, project progress, and commercial value of Xingtu-1, while offering optimization suggestions for key challenges in engineering implementation. Xingtu Helium Energy...
2026-08-24
Taishan Nuclear Power Achieves Full-Process Digitalization for Two Major Environmental Monitoring Inspections
2026-08-24
Argentina advances uranium mine restart to support nuclear power program
2026-08-23
US Boston Dynamics and UK Roke Expand Spot Robot Reconnaissance Applications for Nuclear Facilities
2026-08-23
Armenia to Select Technology Solution for New Nuclear Power Plant by End of 2027
2026-08-23
The city of Brive-la-Gaillarde in the Nouvelle-Aquitaine region of France is using the Sterile Insect Technique (SIT) to control tiger mosquitoes. Since May 2025, the city has been working with the Montpellier-based company Terratis, releasing male mosquitoes that have been treated with X-ray irradiation and rendered incapable of reproduction, in order to reduce the tiger mosquito population. The core of this method is to allow sterile males to mate with wild females, causing the females to lay eggs that cannot hatch. Although it may appear that mosquitoes are still being released in active mosquito areas, the released individuals are males, which do not bite humans. As of October 31, 2025, Brive has deployed nearly 11 million sterile male mosquitoes across 58 release points covering more than 100 hectares, with a weekly release volume of approximately 400,000...
2026-08-23
The International Atomic Energy Agency recently reported that research reactors continue to play a vital role in medical, scientific, industrial innovation, and nuclear workforce development, serving as key infrastructure for many countries to build their nuclear science and technology capabilities. Currently, 228 research reactors are in operation across 54 countries worldwide, with another 23 under construction or in the planning stage. Unlike nuclear power reactors used for electricity generation, research reactors primarily produce neutrons for applications in medicine, industry, agriculture, geological sciences, forensics, and other fields. With capabilities such as neutron irradiation, neutron imaging, elemental analysis, and radioisotope production, research reactors have become important platforms for advancing peaceful nuclear technology applications. In the medical field, research...
2026-08-23
The Texas Department of Public Safety recently highlighted an airborne radiation detection capability being advanced by its Aviation Operations Division. The program integrates specialized radiation detection sensors and real-time data transmission systems onto helicopters, enabling crew members to rapidly survey large areas from the air and relay relevant information to ground personnel in a timely manner, supporting homeland security and security operations for major public events. According to reports, this capability is implemented jointly by the Aviation Operations Division and the Radiation/Nuclear Unit of the Commercial Vehicle Enforcement Division. The equipment has already been used to support security operations for major events, including FIFA-related venues in Houston and Dallas, and will continue to serve...
2026-08-23
Indiana University Health is establishing a new Center of Excellence in Theranostics, planning to provide cancer patients with more personalized diagnostic and treatment services through theranostic technologies. The project combines advanced medical imaging, precision diagnostics, and image-guided targeted therapy, aiming to enhance access to relevant medical services for patients in Indiana. Partial funding comes from a $20 million donor contribution, with Indiana University providing matching funds to bring total donations to $40 million. According to Indiana University, theranostics is a technological approach that integrates diagnosis and treatment. Clinically, advanced imaging techniques are first used...
2026-08-23
A market research report shows that the global Positron Emission Tomography (PET) market size is expected to increase from $1.86 billion in 2025 to $2.81 billion by 2035, with a compound annual growth rate (CAGR) of 4.26% from 2026 to 2035. Increased demand for cancer diagnosis, expanded application of hybrid imaging technologies such as PET-CT and PET-MRI, and continued development of molecular imaging technologies are considered major factors driving market growth. The report notes that PET scans are being increasingly used in scenarios such as cancer detection and treatment evaluation, cardiac disease assessment, and diagnosis of neurological and psychiatric disorders. Meanwhile, population aging, rising healthcare expenditures, and growing demand for early screening are also driving...
2026-08-23
On August 22, the groundbreaking ceremony for the Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project was held in Hengyang, Hunan Province. Officials from Hengyang City and Zhuhui District, representatives from relevant colleges of the University of South China, investment institutions, and relevant personnel from New Radiopharmaceutical Medical attended the event. Cai Jiming, Chairman and President of New Radiopharmaceutical Medical, stated at the ceremony that the project's landing in Hengyang represents an important strategic layout for the company's nuclear medicine business. From contract signing to construction commencement, the project has received support from local governments, partners, and relevant organizations. The company will leverage this project as an opportunity to continue advancing the transformation of innovative achievements in the fields of medical isotopes and radiopharmaceuticals. Wang Jing, Deputy Mayor of Hengyang City, stated that Hengyang...
2026-08-22
Molecular imaging technology company Cubresa Inc. announced on August 20 that its Cubresa BrainPET™ scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). According to the company, the Cubresa BrainPET™ is a positron emission tomography (PET) device specifically designed for brain imaging and can be integrated into existing Siemens Biograph mMR MR/PET systems. The device enables healthcare institutions to perform simultaneous PET/MR brain imaging on existing MRI infrastructure, capturing molecular and anatomical information without the need to purchase a separate whole-body hybrid imaging system. Cubresa founder and CEO James ...
2026-08-22
